Total Payments
$9,818
2024 Payments
$1,610
Companies
35
Transactions
562
Medicare Patients
14,090
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$9,095 (92.6%)
Consulting$700.00 (7.1%)
Education$23.30 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,095 | 558 | 92.6% |
| Consulting Fee | $700.00 | 2 | 7.1% |
| Education | $23.30 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $1,641 | 26 | $0 (2024) |
| Abbott Laboratories | $1,348 | 92 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,035 | 82 | $0 (2024) |
| Amgen Inc. | $773.56 | 53 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $697.40 | 47 | $0 (2024) |
| PFIZER INC. | $681.34 | 49 | $0 (2024) |
| Impulse Dynamics (USA) Inc. | $579.91 | 16 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $479.23 | 32 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $405.36 | 18 | $0 (2024) |
| Amarin Pharma Inc. | $269.24 | 20 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,610 | 83 | Novartis Pharmaceuticals Corporation ($295.12) |
| 2023 | $1,065 | 55 | Impulse Dynamics (USA) Inc. ($257.05) |
| 2022 | $692.65 | 49 | Abbott Laboratories ($188.24) |
| 2021 | $1,461 | 68 | BOSTON SCIENTIFIC CORPORATION ($525.00) |
| 2020 | $643.02 | 41 | Amarin Pharma Inc. ($155.96) |
| 2019 | $1,803 | 118 | Boston Scientific Corporation ($363.03) |
| 2018 | $1,562 | 95 | BOSTON SCIENTIFIC CORPORATION ($399.45) |
| 2017 | $981.39 | 53 | BOSTON SCIENTIFIC CORPORATION ($324.78) |
All Payment Transactions
562 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Abbott Laboratories | NAVITOR (Device) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Vascular | ||||||
| 12/19/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $28.65 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/03/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/03/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Cardiology | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.65 | General |
| Category: Cardiovascular | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $10.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Obesity | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $2.30 | General |
| Category: Cardiovascular | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $8.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/28/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $50.22 | General |
| Category: Cardiovascular Device | ||||||
| 10/22/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: NEUROLOGY | ||||||
| 10/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $6.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/04/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.56 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/04/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Not Applicable | ||||||
| 10/02/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $5.70 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $3.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/11/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $18.42 | General |
| Category: Cardiovascular Device | ||||||
| 09/04/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Genetic Disease | ||||||
| 09/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $10.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 3,756 | 5,207 | $1.3M | $536,509 |
| 2022 | 28 | 3,331 | 4,507 | $1.0M | $417,190 |
| 2021 | 34 | 3,403 | 4,575 | $1.0M | $431,092 |
| 2020 | 25 | 3,600 | 4,633 | $884,817 | $361,799 |
Total Patients
14,090
Total Services
18,922
Medicare Billing
$1.7M
Procedure Codes
134
All Medicare Procedures & Services
134 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 70 | 70 | $343,000 | $153,062 | 44.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 452 | 568 | $141,192 | $54,444 | 38.6% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 70 | 71 | $77,000 | $46,664 | 60.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 300 | 314 | $134,392 | $45,932 | 34.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 373 | 581 | $77,273 | $38,980 | 50.4% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 38 | 38 | $91,200 | $29,080 | 31.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 151 | 151 | $83,050 | $22,129 | 26.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 75 | 411 | $49,320 | $21,611 | 43.8% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 109 | 436 | $28,880 | $17,576 | 60.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 42 | 42 | $40,362 | $14,601 | 36.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 123 | 128 | $37,504 | $14,198 | 37.9% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 67 | 254 | $17,780 | $10,349 | 58.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 79 | 79 | $26,465 | $9,454 | 35.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 63 | 76 | $15,428 | $7,709 | 50.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 136 | 136 | $19,312 | $7,701 | 39.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 59 | 59 | $20,060 | $7,206 | 35.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 509 | 649 | $29,205 | $7,083 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 55 | 58 | $14,442 | $4,820 | 33.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 442 | 539 | $13,475 | $3,686 | 27.4% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 17 | 17 | $9,639 | $3,273 | 34.0% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 36 | 40 | $5,160 | $3,237 | 62.7% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 109 | 109 | $15,587 | $3,181 | 20.4% |
| 99236 | Initial hospital care with same-day admission and discharge with high level of medical decision making, per day, if using time, at least 85 minutes | Facility | 2023 | 11 | 11 | $4,323 | $1,954 | 45.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 15 | $5,100 | $1,906 | 37.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 109 | 109 | $7,521 | $1,263 | 16.8% |
About Dr. Jason Palermo, MD
Dr. Jason Palermo, MD is a Cardiovascular Disease healthcare provider based in Voorhees, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2008. The National Provider Identifier (NPI) number assigned to this provider is 1053561977.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jason Palermo, MD has received a total of $9,818 in payments from pharmaceutical and medical device companies, with $1,610 received in 2024. These payments were reported across 562 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($9,095).
As a Medicare-enrolled provider, Palermo has provided services to 14,090 Medicare beneficiaries, totaling 18,922 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 134 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease, Cardiovascular Disease
- Location Voorhees, NJ
- Active Since 09/27/2008
- Last Updated 05/02/2017
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1053561977
Products in Payments
- XARELTO (Drug) $697.40
- ENTRESTO (Drug) $535.44
- GENERAL THERAPIES (Device) $525.00
- Corlanor (Drug) $524.80
- LEQVIO (Drug) $499.22
- ELIQUIS (Drug) $485.67
- WATCHMAN (Device) $482.60
- LifeVest (Device) $479.23
- Confirm Rx (Device) $431.54
- Fortify Assura, Ellipse ICD (Device) $387.43
- EMBLEM (Device) $334.39
- Optimizer (Device) $313.75
- VYNDAQEL (Drug) $276.19
- Vascepa (Drug) $269.24
- AVEIR (Device) $253.28
- Repatha (Biological) $248.76
- CAMZYOS (Drug) $232.43
- OPTIMIZER (Device) $228.15
- VERQUVO (Drug) $221.58
- GENERAL - THERAPIES (Device) $194.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Voorhees
Elias Iliadis, Md, MD
Cardiovascular Disease — Payments: $159,074
Cardiovascular Disease $159,074
Joseph Parrillo, M.d, M.D
Cardiovascular Disease — Payments: $72,077
Cardiovascular Disease $72,077
Janah Aji, Md, MD
Cardiovascular Disease — Payments: $23,352
Cardiovascular Disease $23,352
Dr. Rajendra Patel, M.d.,F.a.c.c, M.D.,F.A.C.C
Cardiovascular Disease — Payments: $21,934
Cardiovascular Disease $21,934
Ian Joffe, Md, MD
Cardiovascular Disease — Payments: $15,137
Cardiovascular Disease $15,137
Randy Mintz, Md, MD
Cardiovascular Disease — Payments: $11,643
Cardiovascular Disease $11,643